Comerica Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$539K	Sell	1,549 -235	-13%	-$82.2K	0.04%	268
2023 Q2	$628K	Buy	1,784 +14	+0.8%	+$4.72K	0.04%	274
2023 Q1	$558K	Sell	1,770 -422	-19%	-$127K	0.04%	285
2022 Q4	$633K	Sell	2,192 -89	-4%	-$27.1K	0.05%	274
2022 Q3	$660K	Buy	2,281 +58	+3%	+$16.7K	0.05%	254
2022 Q2	$626K	Sell	2,223 -758	-25%	-$203K	0.05%	276
2022 Q1	$778K	Sell	2,981 -296	-9%	-$70.2K	0.05%	272
2021 Q4	$720K	Buy	3,277 +300	+10%	+$58.3K	0.05%	277
2021 Q3	$540K	Buy	2,977 +116	+4%	+$22.6K	0.04%	304
2021 Q2	$577K	Buy	2,861 +798	+39%	+$167K	0.04%	293
2021 Q1	$443K	Buy	2,063 +558	+37%	+$123K	0.03%	334
2020 Q4	$356K	Buy	1,505 +369	+32%	+$84.7K	0.03%	350
2020 Q3	$309K	Buy	1,136 +265	+30%	+$73.1K	0.03%	345
2020 Q2	$253K	Sell	871 -3	-0.3%	-$813	0.02%	366
2020 Q1	$208K	Buy	+874	New	+$200K	0.02%	374
2017 Q1	–	Sell	-6,605	Closed	-$487K	–	408
2016 Q4	$487K	Buy	6,605 +181	+3%	+$14.7K	0.2%	123
2016 Q3	$560K	Buy	+6,424	New	+$607K	0.24%	105